Takafumi Saito

Takafumi Saito

Auto-generated profile, based on publicly available information

Takafumi Saito

Faculty of Rehabilitation, School of Physical Therapy, Reiwa Health Sciences University, Fukuoka, Japan

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2010 in Pituitary
Verified
Journal Article
Closed access
PDF file
YNYoko Nakayama
Yoko Nakayama
SJShinya Jinguji
Shinya Jinguji
SKShin-Ichi Kumakura
Shin-Ichi Kumakura
Keisuke NagasakiKeisuke Nagasaki
Keisuke Nagasaki
MNManabu Natsumeda
Manabu Natsumeda
YFYukihiko Fujii
Yukihiko Fujii

8 February 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
TSTakafumi Saito
Takafumi Saito
Tao ChenTao Chen
Tao Chen
HYHarukaze Yatsugi
Harukaze Yatsugi
TCTianshu Chu
Tianshu Chu
XLXin Liu
Xin Liu
Hiro KishimotoHiro Kishimoto
Hiro Kishimoto
Objectives We investigated the relationship between the number of chronic pain sites and the prevalence and severity of neuropathic-like symptoms in community-dwelling older Japanese adults with chronic pain. Design Cross-sectional study. Setting The data analysed are from a study conducted in the city of Itoshima, Japan in 2017. Participants The study population was 988 participants (age 65–75 years) not in need of long-term care who completed questionnaires assessing sociodemographic factors, psychological factors and chronic pain. Primary outcome measures The primary outcome was the participants’ neuropathic-like symptoms evaluated by the PainDETECT Questionnaire (PD-Q). We classified the participants into mild and moderate-to-severe pain groups according to the pain intensity on the PD-Q. The number of chronic pain sites was categorised into groups with 1, 2–3 and ≥4 sites. Results The age-adjusted and sex-adjusted prevalence of neuropathic-like symptoms was significantly higher among the participants with 2–3 or ≥4 sites compared with the single-site group. In the binomial logistic regression analyses, the multivariable-adjusted ORs and 95% CIs for neuropathic-like symptoms among the participants with 2–3 and ≥4 sites were 1.94 (1.13 to 3.33) and 3.90 (2.22 to 6.85), respectively compared with the participants with single-site pain. The ORs for moderate-to-severe neuropathic-like symptoms increased significantly with the increase in the number of chronic pain sites. Conclusions The number of chronic pain sites was positively associated with the presence and severity of neuropathic-like symptoms in community-dwelling older Japanese adults with chronic pain.

1 October 2007 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
YNYuko Nishise
Yuko Nishise
TSTakafumi Saito
Takafumi Saito
KSKazuhiko Sugahara
Kazuhiko Sugahara
JIJun‐Itsu Ito
Jun‐Itsu Ito
KSKoji Saito
Koji Saito
SKSumio Kawata
Sumio Kawata
We conducted a retrospective study of 65 patients with chronic hepatitis C, to determine whether the secondary structure of the amino-terminal 120 residues of the hepatitis C virus (HCV) NS3 protein is associated with an increased risk of development of hepatocellular carcinoma (HCC). The cumulative incidence of HCC was highest among patients infected with group B HCV-1b, wherein the risk of HCC significantly increased compared with that among patients infected with group A (hazard ratio, 4.95 [95% CI, 1.43–17.11]) after adjustment for age and histological stage. This HCV-1b grouping may be a useful marker for detecting the risk of development of HCC.

9 January 2023 in European journal of pain
Verified
Journal Article
Closed access
TSTakafumi Saito
Takafumi Saito
MSMao Shibata
Mao Shibata
NHNaoki Hirabayashi
Naoki Hirabayashi
THTakanori Honda
Takanori Honda
YMYukiko Morisaki
Yukiko Morisaki
TNToshiharu Ninomiya
Toshiharu Ninomiya

1 August 2023 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
TSTakafumi Saito
Takafumi Saito
XLXin Liu
Xin Liu
HYHarukaze Yatsugi
Harukaze Yatsugi
TCTianshu Chu
Tianshu Chu
TYTsubasa Yokote
Tsubasa Yokote
Hiro KishimotoHiro Kishimoto
Hiro Kishimoto
Purpose: Chronic pain may accelerate the development of frailty in older adults through a variety of mechanisms. There are no published investigations of the influence of neuropathic-like symptoms on physical frailty. We investigated the association between chronic pain types (nociceptive and neuropathic-like symptoms) and frailty in community-dwelling Japanese older adults. Participants and Methods: This was a population-based cross-sectional study conducted in 2017 in the city of Itoshima, Japan of 917 participants aged 65– 75 years, not in need of long-term care, who had completed the physical function tests and questionnaires administered at measurement sessions held at community centers at three sites over a 1- to 2-month period. Their chronic pain types were classified as no-chronic pain, nociceptive pain, and neuropathic-like symptoms according to their painDETECT scores. Frailty phenotypes were defined by the following five components: unintentional weight loss, low grip strength, exhaustion, slow gait speed, and low physical activity. A logistic regression model was used to compute the odds ratios (ORs) and 95% confidence interval (CIs) for frailty status outcomes. Results: The prevalence of pre-frailty was 51.9%, and that of frailty was 5.1%. In multinomial logistic regression analyses, compared to the no-chronic pain group, the OR for the presence of pre-frailty among the participants with nociceptive pain was 1.54 (95% CI: 1.04– 2.30, p=0.03), and the OR for the presence of frailty among the participants with neuropathic-like symptoms was 4.37 (95% CI: 1.10– 17.37, p=0.04). The neuropathic sensory symptoms of burning, tingling/prickling, and numbness were each associated with frailty, but not with the risk of pre-frailty. Conclusion: Neuropathic-like symptoms were significantly associated with the presence of frailty in community-dwelling Japanese older adults. Chronic pain types might have different effects on frailty status.

13 January 2005 in Cancer Science
Verified
Journal Article
Open access
PDF file
SZShu-Jing Zhang
Shu-Jing Zhang
SESumio Endo
Sumio Endo
TSTakafumi Saito
Takafumi Saito
MKMitsuo Kouno
Mitsuo Kouno
TKToshihiko Kuroiwa
Toshihiko Kuroiwa
TKToshiro Kumanishi
Toshiro Kumanishi
Ten primary central nervous system lymphomas (PCNSL, brain lymphomas) were examined for p14 gene exon 1β deletion, mutation and methylation by Southern blot analysis, nucleotide analysis of polymerase chain reaction clones and Southern blot‐based methylation assay. In Southern blot analysis, from the signal densities of the hybridized bands and their similarities to those of exons 2 and 3 in our previous quantitative study, we found that exon 1β was homozygously deleted in four cases, hemizygously deleted in five cases and not deleted in one case. Thus, the same deletion patterns covered the entire p14 gene for all cases except for one case, which suggested the hemizygous deletion of exons 1β and 2 and homozygous deletion of exon 3. In addition, although exon 1β mutation is rare in various tumors, we detected a missense mutation (L50R) in one case with a hemizygous deletion. Methylation of the 5′CpG island of the p14 gene was not suggested for any case without homozygous deletion. Our observation of frequent p14 gene abnormalities (90%) and inactivation (40–60%) was in striking contrast to the same pathological subtype of systemic lymphoma in which p14 gene abnormalities and inactivation were infrequent, suggesting a difference in carcinogenesis between PCNSL and systemic lymphoma. (Cancer Sci 2005; 96: 38 –41)